BENJAMIN WILLETT: Open Payments
NPI 1467722066 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,761 in 138 payments from 23 companies in 2025. Trend: 2023 $531 · 2024 $2,033 · 2025 $7,761
Food & beverage: $3,214Speaker / faculty: $2,352Consulting: $2,016Travel & lodging: $97Education: $82
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 19 | $2,986 |
| Regeneron Healthcare Solutions, Inc. | 21 | $2,717 |
| AstraZeneca Pharmaceuticals LP | 18 | $420 |
| United Therapeutics Corporation | 11 | $221 |
| Merck Sharp & Dohme LLC | 10 | $219 |
| Insmed, Inc. | 14 | $185 |
| GlaxoSmithKline, LLC. | 13 | $182 |
| Mallinckrodt Hospital Products Inc. | 4 | $131 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $92 |
| Baxter Healthcare | 4 | $80 |
Products named: DUPIXENT, Arikayce, ZERBAXA, TEZSPIRE, AIRSUPRA, Tyvaso, BREZTRI, NUCALA.
Industry payments across AR — which companies pay providers there.
